Crossover Randomized Study of Pharmacologic Effects of Ripasudil–Brimonidine Fixed-Dose Combination Versus Ripasudil or Brimonidine

被引：0
|
作者：
Hidenobu Tanihara
Tetsuya Yamamoto
Makoto Aihara
Noriko Koizumi
Hiroomi Minami
Satoshi Kojima
Tomoyuki Isobe
Mizuho Kanazawa
Hideki Suganami
机构：
[1] Biei Municipal Hospital,Department of Ophthalmology
[2] Kaiya Eye Clinic,Prof. Kazuo Iwata Memorial Kaijin Glaucoma Center
[3] The University of Tokyo,Department of Ophthalmology
[4] Doshisha University,Department of Biomedical Engineering, Faculty of Life and Medical Sciences
[5] Kowa Company,Pharmaceutical Clinical Development Management Department
[6] Ltd.,Tokyo New Drug Research Laboratories
[7] Kowa Company,Medical Affairs Department
[8] Ltd.,Data Science Center
[9] Kowa Company,undefined
[10] Ltd.,undefined
[11] Kowa Company,undefined
[12] Ltd.,undefined
来源：
Advances in Therapy | 2023年 / 40卷
关键词：
Conjunctival hyperemia; Corneal endothelial cell; Intraocular pressure; Pupil diameter; Ripasudil–brimonidine fixed-dose combination;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3559 / 3573
页数：14
相关论文
共 50 条
  • [31] Three-Month Randomized Trial of Fixed-Combination Brinzolamide, 1%, and Brimonidine, 0.2%
    Katz, Gregory
    DuBiner, Harvey
    Samples, John
    Vold, Steven
    Sall, Kenneth
    JAMA OPHTHALMOLOGY, 2013, 131 (06) : 724 - 730
  • [32] Comparing the fixed combination brimonidine-timolol versus fixed combination dorzolamide-timolol in patients with elevated intraocular pressure
    Arcieri, Enyr S.
    Arcieri, Rafael S.
    Pereira, Ana C. A.
    Andreo, Eduardo G. V.
    Finotti, Iona G. A.
    Sa Filho, Wanderley F.
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (04) : 683 - 689
  • [33] Fixed-combination Bimatoprost/Brimonidine/Timolol in Glaucoma: A Randomized, Masked, Controlled, Phase III Study Conducted in Brazil
    Belfort Jr, Rubens
    Paula, Jayter Silva
    Lopes Silva, Marcelo Jordao
    Della Paolera, Mauricio
    Kim, Thomas
    Chen, Michelle Y.
    Goodkin, Margot L.
    CLINICAL THERAPEUTICS, 2020, 42 (02) : 263 - 275
  • [34] USE OF DOUBLE FIXED-DOSE COMBINATION OF OLMESARTAN AND AMLODOPINE VERSUS FIXED-DOSE COMBINATION OF LISINIPRIL AND AMLODOPINE IN UNCONTROLLED HYPERTENSIVE PATIENTS
    Koval, Sergey
    Penkova, Marina
    Starcenko, Tatiyana
    Rieznik, Larisa
    JOURNAL OF HYPERTENSION, 2021, 39 : E135 - E135
  • [35] Comparison of the change in intraocular pressure with a fixed-dose combination of brinzolamide 1% and brimonidine 0.2% vs brinzolamide or brimonidine alone in patients with open-angle glaucoma or ocular hypertension: A post hoc, pooled, phase 3 analysis
    Meng, Xiangyi
    Sall, Kenneth N.
    Wirta, David
    Burmaster, Steve
    Cai, Qing
    Bacharach, Jason
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [36] Efficacy and safety of combination therapy with brimonidine 0.2% and latanoprost 0.005% versus fixed combination timolol 0.5%/dorzolamide 2%.
    Zabriskie, NA
    Ahmed, IK
    Cantor, LB
    Kent, AB
    Mundorf, T
    Tauber, J
    Rubin, JM
    Hoop, J
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (04) : S833 - S833
  • [37] Ocular Distribution of Brimonidine and Brinzolamide after Topical Instillation of a 0.1% Brimonidine Tartrate and 1% Brinzolamide Fixed-Combination Ophthalmic Suspension: An Interventional Study
    Orii, Yusuke
    Kunikane, Eriko
    Yamada, Yutaka
    Morioka, Masakazu
    Iwasaki, Kentaro
    Arimura, Shogo
    Mizuno, Akemi
    Inatani, Masaru
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (13)
  • [38] Efficacy and tolerability of fixed-combination bimatoprost/timolol versus fixed-combination dorzolamide/brimonidine/timolol in patients with primary open-angle glaucoma or ocular hypertension: a multicenter, prospective, crossover study
    Garcia-Lopez, Alfonso
    Paczka, Jose A.
    Jimenez-Roman, Jesus
    Hartleben, Curt
    BMC OPHTHALMOLOGY, 2014, 14
  • [39] Twenty-four-hour efficacy of the brimonidine/timolol fixed combination versus therapy with the unfixed components
    A G P Konstas
    I E Katsimpris
    K Kaltsos
    I Georgiadou
    A Kordelou
    L A Nelson
    W C Stewart
    Eye, 2008, 22 : 1391 - 1397
  • [40] Efficacy and tolerability of fixed-combination bimatoprost/timolol versus fixed-combination dorzolamide/brimonidine/timolol in patients with primary open-angle glaucoma or ocular hypertension: a multicenter, prospective, crossover study
    Alfonso García-López
    José A Paczka
    Jesús Jiménez-Román
    Curt Hartleben
    BMC Ophthalmology, 14
12345